Literature DB >> 26219598

Knockout of silent information regulator 2 (SIRT2) preserves neurological function after experimental stroke in mice.

Lea Krey1, Fred Lühder2, Kathrin Kusch3, Bozena Czech-Zechmeister1, Birte Könnecke1, Tiago Fleming Outeiro4, George Trendelenburg1.   

Abstract

Sirtuin-2 (Sirt2) is a member of the NAD(+)-dependent protein deacetylase family. Various members of the sirtuin class have been found to be involved in processes related to longevity, regulation of inflammation, and neuroprotection. Induction of Sirt2 mRNA was found in the whole hemisphere after experimental stroke in a recent screening approach. Moreover, Sirt2 protein is highly expressed in myelin-rich brain regions after stroke. To examine the effects of Sirt2 on ischemic stroke, we induced transient focal cerebral ischemia in adult male Sirt2-knockout and wild-type mice. Two stroke models with different occlusion times were applied: a severe ischemia (45 minutes of middle cerebral artery occlusion (MCAO)) and a mild one (15 minutes of MCAO), which was used to focus on subcortical infarcts. Neurological deficit was determined at 48 hours after 45 minutes of MCAO, and up to 7 days after induction of 15 minutes of cerebral ischemia. In contrast to recent data on Sirt1, Sirt2(-/-) mice showed less neurological deficits in both models of experimental stroke, with the strongest manifestation after 48 hours of reperfusion. However, we did not observe a significant difference of stroke volumes or inflammatory cell count between Sirt2-deficient and wild-type mice. Thus we postulate that Sirt2 mediates myelin-dependent neuronal dysfunction during the early phase after ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26219598      PMCID: PMC4671131          DOI: 10.1038/jcbfm.2015.178

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  35 in total

1.  Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome.

Authors:  Takuma Misawa; Michihiro Takahama; Tatsuya Kozaki; Hanna Lee; Jian Zou; Tatsuya Saitoh; Shizuo Akira
Journal:  Nat Immunol       Date:  2013-03-17       Impact factor: 25.606

2.  The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation.

Authors:  Teresa Faria Pais; Éva M Szegő; Oldriska Marques; Leonor Miller-Fleming; Pedro Antas; Patrícia Guerreiro; Rita Machado de Oliveira; Burcu Kasapoglu; Tiago Fleming Outeiro
Journal:  EMBO J       Date:  2013-09-06       Impact factor: 11.598

3.  CD93/AA4.1: a novel regulator of inflammation in murine focal cerebral ischemia.

Authors:  Denise Harhausen; Vincent Prinz; Gina Ziegler; Karen Gertz; Matthias Endres; Hans Lehrach; Philippe Gasque; Marina Botto; Philip F Stahel; Ulrich Dirnagl; Wilfried Nietfeld; George Trendelenburg
Journal:  J Immunol       Date:  2010-05-03       Impact factor: 5.422

4.  SIRT2 mediates oxidative stress-induced apoptosis of differentiated PC12 cells.

Authors:  Hui Nie; Yunyi Hong; Xiaofei Lu; Jie Zhang; Heyu Chen; Yexin Li; Yingxin Ma; Weihai Ying
Journal:  Neuroreport       Date:  2014-08-06       Impact factor: 1.837

Review 5.  SIRT1 regulation modulates stroke outcome.

Authors:  Valérie Petegnief; Anna M Planas
Journal:  Transl Stroke Res       Date:  2013-08-15       Impact factor: 6.829

6.  Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation.

Authors:  J H Garcia; S Wagner; K F Liu; X J Hu
Journal:  Stroke       Date:  1995-04       Impact factor: 7.914

7.  Silent information regulator 1 protects the brain against cerebral ischemic damage.

Authors:  Macarena Hernández-Jiménez; Olivia Hurtado; María I Cuartero; Iván Ballesteros; Ana Moraga; Jesús M Pradillo; Michael W McBurney; Ignacio Lizasoain; María A Moro
Journal:  Stroke       Date:  2013-05-30       Impact factor: 7.914

8.  Proteolipid protein is required for transport of sirtuin 2 into CNS myelin.

Authors:  Hauke B Werner; Katja Kuhlmann; Siming Shen; Marina Uecker; Anke Schardt; Kalina Dimova; Foteini Orfaniotou; Ajit Dhaunchak; Bastian G Brinkmann; Wiebke Möbius; Lenny Guarente; Patrizia Casaccia-Bonnefil; Olaf Jahn; Klaus-Armin Nave
Journal:  J Neurosci       Date:  2007-07-18       Impact factor: 6.167

9.  Inhibition of Sirtuin 2 with Sulfobenzoic Acid Derivative AK1 is Non-Toxic and Potentially Neuroprotective in a Mouse Model of Frontotemporal Dementia.

Authors:  Tara L Spires-Jones; Leora M Fox; Anete Rozkalne; Rose Pitstick; George A Carlson; Aleksey G Kazantsev
Journal:  Front Pharmacol       Date:  2012-03-12       Impact factor: 5.810

10.  The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemia.

Authors:  Xiqun Chen; Pauline Wales; Luisa Quinti; Fuxing Zuo; Sébastien Moniot; Fanny Herisson; Nazifa Abdul Rauf; Hua Wang; Richard B Silverman; Cenk Ayata; Michelle M Maxwell; Clemens Steegborn; Michael A Schwarzschild; Tiago F Outeiro; Aleksey G Kazantsev
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

View more
  16 in total

1.  SIRT2 Plays Significant Roles in Lipopolysaccharides-Induced Neuroinflammation and Brain Injury in Mice.

Authors:  Ban Wang; Youjun Zhang; Wei Cao; Xunbing Wei; James Chen; Weihai Ying
Journal:  Neurochem Res       Date:  2016-06-27       Impact factor: 3.996

2.  Overexpression of SIRT2 Alleviates Neuropathic Pain and Neuroinflammation Through Deacetylation of Transcription Factor Nuclear Factor-Kappa B.

Authors:  Yong Zhang; Dachao Chi
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

Review 3.  Emerging Roles of Sirtuins in Ischemic Stroke.

Authors:  David T She; Dong-Gyu Jo; Thiruma V Arumugam
Journal:  Transl Stroke Res       Date:  2017-06-27       Impact factor: 6.829

Review 4.  The NAD+-Dependent Family of Sirtuins in Cerebral Ischemia and Preconditioning.

Authors:  Nathalie Khoury; Kevin B Koronowski; Juan I Young; Miguel A Perez-Pinzon
Journal:  Antioxid Redox Signal       Date:  2017-08-07       Impact factor: 8.401

Review 5.  Role of NAD+ and FAD in Ischemic Stroke Pathophysiology: An Epigenetic Nexus and Expanding Therapeutic Repertoire.

Authors:  Parimala Narne; Prakash Babu Phanithi
Journal:  Cell Mol Neurobiol       Date:  2022-09-30       Impact factor: 4.231

Review 6.  Could Sirtuin Activities Modify ALS Onset and Progression?

Authors:  Bor Luen Tang
Journal:  Cell Mol Neurobiol       Date:  2016-12-10       Impact factor: 5.046

7.  Sirtuin-2 mediates male specific neuronal injury following experimental cardiac arrest through activation of TRPM2 ion channels.

Authors:  Kaori Shimizu; Nidia Quillinan; James E Orfila; Paco S Herson
Journal:  Exp Neurol       Date:  2015-10-30       Impact factor: 5.330

8.  Sirtuin 2 enhances allergic asthmatic inflammation.

Authors:  Yong Gyu Lee; Brenda F Reader; Derrick Herman; Adam Streicher; Joshua A Englert; Mathias Ziegler; Sangwoon Chung; Manjula Karpurapu; Gye Young Park; John W Christman; Megan N Ballinger
Journal:  JCI Insight       Date:  2019-02-21

9.  Sirt3 Protects Against Ischemic Stroke Injury by Regulating HIF-1α/VEGF Signaling and Blood-Brain Barrier Integrity.

Authors:  Xiao Yang; Yanshuang Zhang; Keyi Geng; Ke Yang; Jiaxiang Shao; Weiliang Xia
Journal:  Cell Mol Neurobiol       Date:  2020-06-04       Impact factor: 5.046

10.  Sirtuin 2 Deficiency Increases Bacterial Phagocytosis by Macrophages and Protects from Chronic Staphylococcal Infection.

Authors:  Eleonora Ciarlo; Tytti Heinonen; Charlotte Théroude; Jacobus Herderschee; Matteo Mombelli; Jérôme Lugrin; Marc Pfefferlé; Beatrice Tyrrell; Sarah Lensch; Hans Acha-Orbea; Didier Le Roy; Johan Auwerx; Thierry Roger
Journal:  Front Immunol       Date:  2017-08-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.